NCT03478826 Creation of a Biospecimen Repository From Patients With Interstitial Lung Diseases (ILD)
| NCT ID | NCT03478826 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Mayo Clinic |
| Condition | Interstitial Lung Disease |
| Study Type | OBSERVATIONAL |
| Enrollment | 635 participants |
| Start Date | 2018-08-01 |
| Primary Completion | 2028-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 635 participants in total. It began in 2018-08-01 with a primary completion date of 2028-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
To develop a repository of blood samples from patients with ILD to support future studies into the development of such biomarkers. Patients with pneumonia and healthy patients will also be recruited as a control group.
Eligibility Criteria
Inclusion Criteria: * Patients with a diagnosis of ILD or any fibrotic disease of the lung or a diagnosis of pneumonia * Patients willing to provide written informed consent Exclusion Criteria: * Unwillingness/unable to give blood samples
Contact & Investigator
Eva M Carmona Porquera, MD, PhD
PRINCIPAL INVESTIGATOR
Mayo Clinic
Frequently Asked Questions
Who can join the NCT03478826 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Interstitial Lung Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03478826 currently recruiting?
Yes, NCT03478826 is actively recruiting participants. Contact the research team at Stachowitz.Michael@mayo.edu for enrollment information.
Where is the NCT03478826 trial being conducted?
This trial is being conducted at Rochester, United States.
Who is sponsoring the NCT03478826 clinical trial?
NCT03478826 is sponsored by Mayo Clinic. The principal investigator is Eva M Carmona Porquera, MD, PhD at Mayo Clinic. The trial plans to enroll 635 participants.